Kristin Wickham, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-7200 |
Robert G. Holzknecht, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 S Main St, Madisonville, KY 42431 Phone: 270-821-4444 Fax: 270-821-9188 |
Richard G King, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-7200 |
Catherine S Montz, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-6680 Fax: 270-825-7266 |
Michael Jones, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 230 Madison Square Dr Ste C, Madisonville, KY 42431 Phone: 270-821-6262 |
Robert Lamont Wood, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-6680 Fax: 270-825-7266 |
Marium Iqbal, Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-6680 Fax: 270-825-7266 |
John J. Farmer, M. D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 S Main St, Madisonville, KY 42431 Phone: 270-821-4444 Fax: 270-821-9188 |
Forrest A Hanke, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-7200 |
James M Bowles, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-7200 |
Andrew Banks, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-6680 |
Robert C Hughes, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 510 Ruby Dr, Madisonville, KY 42431 Phone: 270-399-7900 Fax: 270-399-7910 |
William J Crump Jr., MD Family Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-7200 |
Shannon Arora, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-7200 Fax: 270-825-7266 |
Folaranmi Ajiboye, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-6690 Fax: 270-825-7266 |
Jennifer C. Jackson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-7200 |
Kenneth R. Hargrove, M. D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-7200 |
Deborah S Gregory, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 900 Hospital Dr, Madisonville, KY 42431 Phone: 270-825-5100 |
Abraham S. Galloway, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 S Main St, Madisonville, KY 42431 Phone: 270-821-4444 Fax: 270-824-6631 |
Charles Dodds, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-7200 |
News Archive
The worm C. elegans seems an unlikely candidate for studies related to cardiac arrhythmias. After all, the microscopic organism doesn't even have a heart.
Dyax Corp. announced today treatment of the first patient in a Phase 2 trial evaluating the efficacy and safety of ecallantide, a potent, selective, reversible inhibitor of plasma kallikrein, for acute treatment of angiotensin converting enzyme (ACE) inhibitor-induced angioedema.
Researchers who investigated the level of kidney function and subsequent cancer risk in more than one million adults have found that reduced glomerular filtration rate (GFR) — a key measure of reduced kidney function and chronic kidney disease (CKD) — is an independent risk factor for renal and urothelial cancer but not other cancer types.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that in collaboration with OXiGENE, Professor Gordon Rustin and colleagues from the Mount Vernon Cancer Research Centre, UK and other institutions in the United Kingdom, reported positive final data from an investigator-sponsored Phase 1 study of OXi4503 in patients with solid tumors.
MiMedx Group, Inc. announced today that it has officially launched its first product, Paradis Vaso Shield(TM). In April 2009, The Food and Drug Administration cleared the Vaso Shield for use as a cover for vessels following anterior vertebral surgeries. The Vaso Shield is a permanent and transparent hydrogel product protected by multiple patents and patent applications, as well as a proprietary manufacturing process.
› Verified 7 days ago